The Shift to Chronic Care
The disease profile of India is rapidly changing. While acute care (like antibiotics) remains steady, the real growth is in chronic care management. In 2026, we advise our partners to build their portfolio around these high-growth segments:
1. Cardio-Metabolic (Diabetic)
Lifestyle diseases are at an all-time high. Drugs for hypertension and glycemic control are high-volume, repeat-purchase items.
2. Neuro-Psychiatry
Mental health awareness is increasing, leading to a surge in demand for high-quality neuropathic and psychiatric formulations.
3. Nutraceuticals & Lifestyle Wellness
Prevention is becoming a priority. Vitamins, antioxidants, and wellness supplements are now a significant portion of a successful distributor's revenue.
#TherapeuticSegments#CardiacDiabeticFranchise#PharmaTrends2026